MM patients have shown a more favorable CD34 cell count than Lymphoma patients (OR = 4.349, P = 0.027) however this favoritism was to a lesser extent after mobilization with GCSF and plerixafor. The gene discussed is CD34; the disease is Miyoshi myopathy.